Navigation Links
BioElectronics' Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
Date:4/25/2012

FREDERICK, Md., April 25, 2012 /PRNewswire/ -- BioElectronics Corporation (OTC-PINK: BIEL), the maker of disposable, inexpensive drug-free topical pain and healing devices, today announced the results of a customer survey.  The results indicate that patients using BIEL's ActiPatch® therapy report a five-fold greater pain reduction than those using non-steroidal anti-inflammatory products such as ibuprofen and aspirin.

ActiPatch Therapy, which uses pulsed shortwave therapy based on large expensive machines used in clinics and hospitals, was most frequently used to treat lower back pain by participants in the survey.  Lower back pain is a major health problem in western industrialized countries and a major cause of medical expenses and disablement.

"The most widely used OTC drugs have a significant number of side effects, are minimally effective and have only short-term symptomatic relief," said Ian Rawe, Ph.D., BioElectronics Director of Clinical Research. "In comparison, ActiPatch users who participated in the survey had a five-fold greater pain reduction than persons using non-steroidal anti-inflammatory drugs, based on a comparison to published clinical data. Additionally, with ActiPatch's all-day safe pain relief, people can resume their normal daily activities."

"We are very pleased by the results of our consumer survey, which confirms our clinical studies in which ActiPatch users as compared to users of OTC pain medications, have greater pain relief and an improved quality of life," Dr. Rawe said. "An increased consumer awareness of the dangers of overuse of oral analgesics such as acetaminophen and non-steroidal anti-inflammatory drugs has significantly altered the competitive landscape for pain management therapeutics. There is significant need for an improved efficacy, competitively priced over-the-counter therapeutic agent with no side-effects."

Results of the survey, which also show that patients would recommend ActiPatch® to a friend and would themselves purchase another ActiPatch® if the need arose, can be viewed at: www.bielcorp.com/survey.

About BioElectronics Corporation

BioElectronics is an award winning developer and manufacturer of advanced medical devices. Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal ailments, the Allay™ Menstrual Cycle Pain Therapy, and RecoveryRx™ for surgical procedures and wound care. The unique therapy delivery system, using patented technology, provides a cost-effective home care method to reduce soft tissue pain and swelling. For more information, please visit www.bielcorp.com.

Contact:  E & E Communications
Paul Knopick
(949) 707-5365


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. BioElectronics Study on Plantar Fasciitis to be Published in The Journal of Foot and Ankle Surgery
2. BioElectronics Corporation to Webcast, Live, at RetailInvestorConferences.com on October 6th
3. YesDTC Holdings and BioElectronics Receive Japanese Regulatory Review Date
4. BioElectronics and YesDTC Holdings Receive Japanese Regulatory Review Date
5. BioElectronics Announces Profitability Breakeven and Additional Clinical Trials
6. BioElectronics Announces Major Clinical Trials
7. KPMG Survey: Medical Device Execs Say New Excise Tax Will Hit Their Company Bottom Lines Hard
8. Survey Shows Anesthesiologists Prefer Capnography for Monitoring Adequacy of Ventilation
9. New Survey: Walgreens Customers Flock to Independent Pharmacies
10. PAREXEL Global Survey Results Identify Top Concerns of Biopharma Industry in Achieving Commercial Success
11. Pevion Mandated Patient Survey Confirms Disease Burden of Recurrent Vulvovaginal Candidiasis (RVVC) and Indicates Public Health Problem
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/9/2017)... , May 9, 2017  Oramed Pharmaceuticals Inc. ... a clinical-stage pharmaceutical company focused on the development ... the Canadian Intellectual Property Office has granted Oramed ... Administration of Exenatide". The patent covers Oramed,s invention ... GLP-1 is an incretin hormone that stimulates ...
(Date:5/6/2017)... , May 5, 2017  May is Stroke ... one of the most important methods to prevent a ... the Centers for Disease Control and Prevention, undetected and ... 1 Omron, the global leader in personal heart ... the elimination of heart attack and stroke and is ...
(Date:5/4/2017)... DIEGO , May 4, 2017  The American ... and Scientific Meeting— OBP Medical , a leading global ... the launch of a new extra-small size and first-in-market ... ER-SPEC vaginal specula. Already available in small, medium, ... makes OBP Medical,s line of single-use lighted specula the ...
Breaking Medicine Technology:
(Date:5/24/2017)... , ... May 24, 2017 , ... ... background. Understanind and choosing the most appropriate instruments for research and understanding the ... research finding. This webinar will focus on innovations in stereo microscopy for brightfield ...
(Date:5/24/2017)... ... ... Dr. Manju R. Kejriwal, a leading Ohio dentist, is now welcoming new ... Dr. Kejriwal understands the emotional and financial toll traditional orthodontics can take on patients’ ... longer need to feel the esthetic effects of wires and brackets when they can ...
(Date:5/24/2017)... , ... May 24, 2017 ... ... the female reproductive tract in which the endometrial lining of the uterus ... inflammation and pain. Patients experiencing painful intercourse, painful periods, pelvic pain, or ...
(Date:5/24/2017)... ... May 24, 2017 , ... Rob Lowe is a sought after ... Public Television. “Informed” brings the public important topics from all aspects of life, and ... feet and issues surrounding feet and ankles. , Podiatry is essential to people’s overall ...
(Date:5/23/2017)... ... May 23, 2017 , ... MDLand International (MDLand), ... announced today that its iClinic V12.2 solution has achieved approval from National Center ... introduced PCMH 2017 standards which emphasize team-based care with a significant focus on ...
Breaking Medicine News(10 mins):